News

AdvanSource Biomaterials Corporation announces that it has received a notice of allowance from the U.S. Patent and Trademark Office in connection with its patent application for an antimicrobial polymer designed to help fight MRSA infections caused by medical devices.

Although immunity to mumps is high in the United States, mumps vaccine coverage must be maintained and improved to prevent future outbreaks, according to a new study.

While vancomycin-resistant enterococci (VRE) have triggered multiple outbreaks, VRE of genotype vanC appear not to be associated with outbreaks, according to Sutter, et al. (2010).

Antimicrobial resistance, the ability of microorganisms to find ways to evade the action of the drugs used to cure the infections they cause, is increasingly recognized as a global public health issue which could hamper the control of many infectious diseases.